Apolipoprotein E isoform-specific disruption of phosphoinositide hydrolysis: Protection by estrogen and glutathione

14Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The mechanism(s) by which the E4 isoform of apolipoprotein E (apoE4) influences Alzheimer's disease (AD) are not fully known. We report that apoE4, but not apoE3, disrupts carbachol-stimulated phosphoinositide (PI) hydrolysis in SH-SY5Y neuroblastoma cells. Carbachol responses were also disrupted by β-amyloid (Aβ) (1-42) and apoE4/Aβ(1-42) complexes, but not by apoE3/Aβ(1-42). Glutathione and estrogen protected against apoE4 and Aβ(1-42) effects, as well as those of H2O2. Estrogen protection was partially blocked by wortmannin, suggesting the involvement of phosphatidylinositol 3-kinase. An apoE4-induced disruption of acetylcholine muscarinic receptor-mediated signalling may explain the lower effectiveness of cholinergic replacement treatments in apoE4 AD patients. Also, the beneficial effect of estrogen in AD may be partially due to its ability to protect against apoE4- and Aβ(1-42)-mediated disruption of PI hydrolysis. © 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.

Cite

CITATION STYLE

APA

Cedazo-Mínguez, A., & Cowburn, R. F. (2001). Apolipoprotein E isoform-specific disruption of phosphoinositide hydrolysis: Protection by estrogen and glutathione. FEBS Letters, 504(1–2), 45–49. https://doi.org/10.1016/S0014-5793(01)02761-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free